August 17, 2009 — An experimental GE Healthcare imaging agent called DaTSCAN that can detect loss of dopaminergic neurons — seen in diseases such as Parkinson's disease (PD) and dementia with Lewy ...

DaTscan is a radioactive diagnostic agent that works by binding reversibly to the human dopamine transporter (DaT) in the brain. The Food and Drug Administration (FDA) has expanded the approval of ...

Determining the specific type of dementia early in the diagnostic process can lead to more targeted treatments and better ...

(RTTNews) - GE Healthcare (GE) announced on Thursday that DaTscan was approved by FDA for use in patients with suspected Dementia with Lewy Bodies or DLB. DaTscan is a radiopharmaceutical imaging ...